Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

科研成果: 期刊稿件文章同行评审

239 引用 (Scopus)
源语言英语
页(从-至)161-169
页数9
期刊The Lancet
400
10347
DOI
出版状态已出版 - 7月 16 2022

!!!ASJC Scopus Subject Areas

  • 一般医学

指纹

探究 'Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial' 的科研主题。它们共同构成独一无二的指纹。

引用此

(编辑) (2022). Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. The Lancet, 400(10347), 161-169. https://doi.org/10.1016/S0140-6736(22)01054-6